{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:58:09Z","timestamp":1788245889079,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["99000897"],"award-info":[{"award-number":["99000897"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01097-w","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:19:45Z","timestamp":1746836385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The synergistic anti-leishmanial effect of photodynamic therapy employing chemotherapy-mediated nanocomposites"],"prefix":"10.1038","volume":"15","author":[{"given":"Elahe","family":"Molaakbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Bamorovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Zarif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"1097_CR1","doi-asserted-by":"publisher","first-page":"e0007423","DOI":"10.1371\/journal.pntd.0007423","volume":"13","author":"MR Aflatoonian","year":"2019","unstructured":"Aflatoonian, M. R. et al. Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with Meglumine antimoniate: A cohort study in Iran. PLoS Negl. Trop. Dis. 13, e0007423 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1097_CR2","doi-asserted-by":"publisher","first-page":"e0010745","DOI":"10.1371\/journal.pntd.0010745","volume":"16","author":"G Pasquier","year":"2022","unstructured":"Pasquier, G. et al. Leishmaniasis epidemiology in endemic areas of metropolitan France and its overseas territories from 1998 to 2020. PLoS Negl. Trop. Dis. 16, e0010745. https:\/\/doi.org\/10.1371\/journal.pntd.0010745 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1097_CR3","first-page":"182","volume":"42","author":"A Khosravi","year":"2013","unstructured":"Khosravi, A., Sharifi, I., Dortaj, E., Afshar, A. A. & Mostafavi, M. The present status of cutaneous leishmaniasis in a recently emerged focus in south-west of Kerman Province, Iran. Iran. J. Public. Health. 42, 182 (2013).","journal-title":"Iran. J. Public. Health"},{"key":"1097_CR4","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","volume":"104","author":"BM Roatt","year":"2020","unstructured":"Roatt, B. M. et al. Recent advances and new strategies on leishmaniasis treatment. Appl. Microbiol. Biotechnol. 104, 8965\u20138977 (2020).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"1097_CR5","first-page":"718","volume":"13","author":"SE Eskandari","year":"2021","unstructured":"Eskandari, S. E. et al. Combination of topical liposomal amphotericin B and glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by leishmania tropica: study protocol for a randomized, controlled trial. Iran. J. Microbiol. 13, 718 (2021).","journal-title":"Iran. J. Microbiol."},{"key":"1097_CR6","doi-asserted-by":"publisher","unstructured":"Albalawi, A. E. et al. Therapeutic potential of green synthesized copper nanoparticles alone or combined with meglumine antimoniate (Glucantime(\u00ae)) in cutaneous leishmaniasis. Nanomaterials (Basel). 11 https:\/\/doi.org\/10.3390\/nano11040891 (2021).","DOI":"10.3390\/nano11040891"},{"key":"1097_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tiv.2018.12.018","volume":"56","author":"A Khosravi","year":"2019","unstructured":"Khosravi, A. et al. Toxico-pathological effects of Meglumine antimoniate on human umbilical vein endothelial cells. Toxicol. In Vitro. 56, 10\u201318 (2019).","journal-title":"Toxicol. In Vitro"},{"key":"1097_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbrc.2018.09.152","volume":"505","author":"A Khosravi","year":"2018","unstructured":"Khosravi, A. et al. Vascular apoptosis associated with Meglumine antimoniate: in vivo investigation of a chick embryo model. Biochem. Biophys. Res. Commun. 505, 794\u2013800 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1097_CR9","doi-asserted-by":"publisher","first-page":"174934","DOI":"10.1016\/j.ejphar.2022.174934","volume":"923","author":"JP Assolini","year":"2022","unstructured":"Assolini, J. P. et al. Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease-An update overview. Eur. J. Pharmacol. 923, 174934 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"1097_CR10","doi-asserted-by":"publisher","first-page":"174934","DOI":"10.1016\/j.ejphar.2022.174934","volume":"923","author":"JP Assolini","year":"2022","unstructured":"Assolini, J. P. et al. Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview. Eur. J. Pharmacol. 923, 174934. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174934 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"1097_CR11","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/s41598-024-52620-4","volume":"14","author":"F Seyedi","year":"2024","unstructured":"Seyedi, F. et al. Comparison of cytotoxicity of miltefosine and its Niosomal form on chick embryo model. Sci. Rep. 14, 2482 (2024).","journal-title":"Sci. Rep."},{"key":"1097_CR12","doi-asserted-by":"publisher","first-page":"860598","DOI":"10.3389\/fphar.2022.860598","volume":"13","author":"A Khosravi","year":"2022","unstructured":"Khosravi, A. et al. Cytotoxicity of amphotericin B and ambisome: in Silico and in vivo evaluation employing the chick embryo model. Front. Pharmacol. 13, 860598 (2022).","journal-title":"Front. Pharmacol."},{"key":"1097_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1086\/655134","volume":"51","author":"U Gonzalez","year":"2010","unstructured":"Gonzalez, U. et al. Designing and reporting clinical trials on treatments for cutaneous leishmaniasis. Clin. Infect. Dis. 51, 409\u2013419 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"1097_CR14","doi-asserted-by":"publisher","first-page":"e0184777","DOI":"10.1371\/journal.pone.0184777","volume":"12","author":"NC Brito","year":"2017","unstructured":"Brito, N. C., Rabello, A. & Cota, G. F. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review. PLoS One. 12, e0184777 (2017).","journal-title":"PLoS One"},{"key":"1097_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.micpath.2018.12.040","volume":"128","author":"M Bamorovat","year":"2019","unstructured":"Bamorovat, M. et al. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: levamisole in combination with glucantime in field and laboratory models. Microb. Pathog. 128, 162\u2013170 (2019).","journal-title":"Microb. Pathog."},{"key":"1097_CR16","doi-asserted-by":"publisher","first-page":"106704","DOI":"10.1016\/j.intimp.2020.106704","volume":"86","author":"RT Oliaee","year":"2020","unstructured":"Oliaee, R. T. et al. The potential role of nicotinamide on leishmania tropica: an assessment of inhibitory effect, cytokines gene expression and arginase profiling. Int. Immunopharmacol. 86, 106704 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"1097_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.micpath.2018.01.021","volume":"116","author":"M Bamorovat","year":"2018","unstructured":"Bamorovat, M. et al. Leishmania tropica isolates from non-healed and healed patients in Iran: A molecular typing and phylogenetic analysis. Microb. Pathog. 116, 124\u2013129 (2018).","journal-title":"Microb. Pathog."},{"key":"1097_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.intimp.2019.02.008","volume":"69","author":"M Bamorovat","year":"2019","unstructured":"Bamorovat, M. et al. Host\u2019s immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by Meglumine antimoniate: A case-control study of Th1 and Th2 pathways. Int. Immunopharmacol. 69, 321\u2013327 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"1097_CR19","doi-asserted-by":"publisher","first-page":"e0135707","DOI":"10.1371\/journal.pone.0135707","volume":"10","author":"JP Tardivo","year":"2015","unstructured":"Tardivo, J. P., Baptista, M. S., Correa, J. A., Adami, F. & Pinhal, M. A. S. Development of the tardivo algorithm to predict amputation risk of diabetic foot. PLoS One. 10, e0135707 (2015).","journal-title":"PLoS One"},{"key":"1097_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pdpdt.2018.05.005","volume":"23","author":"DP Aureliano","year":"2018","unstructured":"Aureliano, D. P. et al. Cell death mechanisms in leishmania amazonensis triggered by methylene blue-mediated antiparasitic photodynamic therapy. Photodiagn. Photodyn. Ther. 23, 1\u20138. https:\/\/doi.org\/10.1016\/j.pdpdt.2018.05.005 (2018).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"1097_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-2007-1001289","volume":"30","author":"H Van den Bergh","year":"1998","unstructured":"Van den Bergh, H. On the evolution of some endoscopic light delivery systems for photodynamic therapy. Endoscopy. 30, 392\u2013407 (1998).","journal-title":"Endoscopy"},{"key":"1097_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.oraloncology.2003.09.003","volume":"40","author":"C Hopper","year":"2004","unstructured":"Hopper, C., Niziol, C. & Sidhu, M. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol. 40, 372\u2013382 (2004).","journal-title":"Oral Oncol."},{"key":"1097_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1023\/A:1024146823549","volume":"48","author":"C Hur","year":"2003","unstructured":"Hur, C., Nishioka, N. S. & Gazelle, G. S. Cost-effectiveness of photodynamic therapy for treatment of Barrett\u2019s esophagus with high grade dysplasia. Dig. Dis. Sci. 48, 1273\u20131283 (2003).","journal-title":"Dig. Dis. Sci."},{"key":"1097_CR24","doi-asserted-by":"publisher","first-page":"10093","DOI":"10.1038\/srep10093","volume":"5","author":"J Hempstead","year":"2015","unstructured":"Hempstead, J. et al. Low-cost photodynamic therapy devices for global health settings: characterization of battery-powered LED performance and smartphone imaging in 3D tumor models. Sci. Rep. 5, 10093 (2015).","journal-title":"Sci. Rep."},{"key":"1097_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/lsm.20327","volume":"38","author":"BW Henderson","year":"2006","unstructured":"Henderson, B. W., Busch, T. M. & Snyder, J. W. Fluence rate as a modulator of PDT mechanisms. Lasers Surg. Med. 38, 489\u2013493 (2006).","journal-title":"Lasers Surg. Med."},{"key":"1097_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pdpdt.2008.02.001","volume":"5","author":"R Allison","year":"2008","unstructured":"Allison, R., Mota, H., Bagnato, V. S. & Sibata, C. Bio-nanotechnology and photodynamic therapy\u2014State of the Art review. Photodiagn. Photodyn. Ther. 5, 19\u201328 (2008).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"1097_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1021\/acsnano.1c08474","volume":"16","author":"TS Le","year":"2022","unstructured":"Le, T. S. et al. Quick and mild isolation of intact lysosomes using magnetic\u2013plasmonic hybrid nanoparticles. ACS Nano. 16, 885\u2013896 (2022).","journal-title":"ACS Nano"},{"key":"1097_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0025-5408(03)00129-6","volume":"38","author":"J Wang","year":"2003","unstructured":"Wang, J., Sun, J., Sun, Q. & Chen, Q. One-step hydrothermal process to prepare highly crystalline Fe3O4 nanoparticles with improved magnetic properties. Mater. Res. Bull. 38, 1113\u20131118 (2003).","journal-title":"Mater. Res. Bull."},{"key":"1097_CR29","doi-asserted-by":"crossref","unstructured":"Van Uitert, L. d. Dc resistivity in the nickel and nickel zinc ferrite system. J. Chem. Phys. 23, 1883\u20131887 (1955).","DOI":"10.1063\/1.1740598"},{"key":"1097_CR30","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.1016\/j.actbio.2013.08.016","volume":"9","author":"J Liu","year":"2013","unstructured":"Liu, J., Cui, L. & Losic, D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 9, 9243\u20139257 (2013).","journal-title":"Acta Biomater."},{"key":"1097_CR31","doi-asserted-by":"publisher","first-page":"993281","DOI":"10.3389\/fnagi.2022.993281","volume":"14","author":"G Song","year":"2022","unstructured":"Song, G. et al. Aptamer-conjugated graphene oxide-based surface assisted laser desorption ionization mass spectrometry for selective extraction and detection of A\u03b21\u201342 in an Alzheimer\u2019s disease SH-SY5 cell model. Front. Aging Neurosci. 14, 993281 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1097_CR32","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/asia.201700814","volume":"12","author":"P Zheng","year":"2017","unstructured":"Zheng, P. & Wu, N. Fluorescence and sensing applications of graphene oxide and graphene quantum Dots: a review. Chem. Asian J. 12, 2343\u20132353 (2017).","journal-title":"Chem. Asian J."},{"key":"1097_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.04.006","volume":"95","author":"P Kalluru","year":"2016","unstructured":"Kalluru, P., Vankayala, R., Chiang, C. S. & Hwang, K. C. Nano-graphene oxide-mediated in vivo fluorescence imaging and bimodal photodynamic and photothermal destruction of tumors. Biomaterials 95, 1\u201310 (2016).","journal-title":"Biomaterials"},{"key":"1097_CR34","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.matdes.2010.08.053","volume":"32","author":"P Fannin","year":"2011","unstructured":"Fannin, P. et al. Microwave absorbent properties of nanosized Cobalt ferrite powders prepared by coprecipitation and subjected to different thermal treatments. Mater. Design. 32, 1600\u20131604 (2011).","journal-title":"Mater. Des."},{"key":"1097_CR35","doi-asserted-by":"crossref","unstructured":"Popescu, S. A. et al. Synthesis, morphology and magnetic characterization of Zn ferrite powders. J. Electromagn. Anal. Appl. (2010).","DOI":"10.4236\/jemaa.2010.210078"},{"key":"1097_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nmat1849","volume":"6","author":"AK Geim","year":"2007","unstructured":"Geim, A. K. & Novoselov, K. S. The rise of graphene. Nat. Mater. 6, 183\u2013191 (2007).","journal-title":"Nat. Mater."},{"key":"1097_CR37","doi-asserted-by":"crossref","unstructured":"Banerjee, S. S., Aher, N., Patil, R. & Khandare, J. Poly (ethylene glycol)-prodrug conjugates: concept, design, and applications. J. Drug Deliv. 2012, 103973 (2012).","DOI":"10.1155\/2012\/103973"},{"key":"1097_CR38","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1016\/j.biomaterials.2011.07.071","volume":"32","author":"W Zhang","year":"2011","unstructured":"Zhang, W. et al. Synergistic effect of chemo-photothermal therapy using pegylated graphene oxide. Biomaterials 32, 8555\u20138561 (2011).","journal-title":"Biomaterials"},{"key":"1097_CR39","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1002\/slct.201900695","volume":"4","author":"KP Boroujeni","year":"2019","unstructured":"Boroujeni, K. P., Tohidiyan, Z., Fadavi, A., Eskandari, M. M. & Shahsanaei, H. A. Synthesis and catalytic application of Poly (2-acrylamido\u20102\u2010methyl\u20101\u2010propanesulfonic acid\u2010co\u2010acrylamide) grafted on graphene oxide. ChemistrySelect. 4, 7734\u20137744 (2019).","journal-title":"ChemistrySelect"},{"key":"1097_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.pdpdt.2019.04.004","volume":"26","author":"JBP Ribeiro","year":"2019","unstructured":"Ribeiro, J. B. P. et al. Study of the efficacy of N-methyl glucamine antimoniate (SbV) associated with photodynamic therapy using liposomal Chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by leishmania (L.) amazonensis in C57BL6 mice. Photodiagn. Photodyn. Ther. 26, 261\u2013269 (2019).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"1097_CR41","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1039\/C5RA15862A","volume":"5","author":"M Ashjari","year":"2015","unstructured":"Ashjari, M., Dehfuly, S., Fatehi, D., Shabani, R. & Koruji, M. Efficient functionalization of gold nanoparticles using cysteine conjugated protoporphyrin IX for singlet oxygen production in vitro. RSC Adv. 5, 104621\u2013104628 (2015).","journal-title":"RSC Adv."},{"key":"1097_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.apcatb.2014.04.026","volume":"158","author":"AA Mansur","year":"2014","unstructured":"Mansur, A. A., Mansur, H. S., Ramanery, F. P., Oliveira, L. C. & Souza, P. P. Green colloidal ZnS quantum Dots\/chitosan nano-photocatalysts for advanced oxidation processes: study of the photodegradation of organic dye pollutants. Appl. Catal. B. 158, 269\u2013279 (2014).","journal-title":"Appl. Catal. B"},{"key":"1097_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.apcata.2006.09.027","volume":"316","author":"L Oliveira","year":"2007","unstructured":"Oliveira, L. et al. A new catalyst material based on niobia\/iron oxide composite on the oxidation of organic contaminants in water via heterogeneous Fenton mechanisms. Appl. Catal. A. 316, 117\u2013124 (2007).","journal-title":"Appl. Catal. A"},{"key":"1097_CR44","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.1016\/j.intimp.2021.108274","volume":"101","author":"A Keyhani","year":"2021","unstructured":"Keyhani, A. et al. In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of leishmania major infection: powerful synergistic and multifunctional effects. Int. Immunopharmacol. 101, 108274 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"1097_CR45","first-page":"776","volume":"63","author":"LK Folkes","year":"2003","unstructured":"Folkes, L. K. & Wardman, P. Enhancing the efficacy of photodynamic cancer therapy by radicals from plant auxin (indole-3-acetic acid). Cancer Res. 63, 776\u2013779 (2003).","journal-title":"Cancer Res."},{"key":"1097_CR46","doi-asserted-by":"publisher","first-page":"220058","DOI":"10.1098\/rsos.220058","volume":"9","author":"N Goonoo","year":"2022","unstructured":"Goonoo, N. et al. Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis. R. Soc. Open. Sci. 9, 220058 (2022).","journal-title":"R. Soc. Open. Sci."},{"key":"1097_CR47","first-page":"13","volume":"1","author":"N Torabi","year":"2011","unstructured":"Torabi, N. et al. Nanogold for the treatment of zoonotic cutaneous leishmaniasis caused by leishmania major (MRHO\/IR\/75\/ER): an animal trial with methanol extract of Eucalyptus camaldulensis. JPHS 1, 13\u201316 (2011).","journal-title":"JPHS"},{"key":"1097_CR48","unstructured":"Mohebali, M. et al. Nanosilver in the treatment of localized cutaneous leishmaniasis caused by leishmania major (MRHO\/IR\/75\/ER): an in vitro and in vivo study. (2009)."},{"key":"1097_CR49","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00436-019-06382-y","volume":"118","author":"S Mohtasebi","year":"2019","unstructured":"Mohtasebi, S. et al. In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on leishmania major (MRHO\/IR\/75\/ER). Parasitol. Res. 118, 2669\u20132678 (2019).","journal-title":"Parasitol. Res."},{"key":"1097_CR50","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.21577\/1984-6835.20160139","volume":"8","author":"MM Bastos","year":"2016","unstructured":"Bastos, M. M., Hoelz, B., Boechat, L. V., de Oliveira, A. P. & N. & Antileishmanial chemotherapy: A literature review. Revista Virtual De Qu\u00edmica. 8, 2072\u20132104 (2016).","journal-title":"Revista Virtual De Qu\u00edmica"},{"key":"1097_CR51","doi-asserted-by":"crossref","unstructured":"Franco, A. M. et al. Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs. Int. J. Nanomed. 6771\u20136780 (2016).","DOI":"10.2147\/IJN.S121096"},{"key":"1097_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke, A., Kiderlen, A. & Kayser, O. Amphotericin B. Appl. Microbiol. Biotechnol. 68, 151\u2013162 (2005).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"1097_CR53","doi-asserted-by":"publisher","first-page":"e00156","DOI":"10.1016\/j.parepi.2020.e00156","volume":"10","author":"A Nafari","year":"2020","unstructured":"Nafari, A. et al. Nanoparticles: new agents toward treatment of leishmaniasis. Parasite Epidemiol. Control. 10, e00156. https:\/\/doi.org\/10.1016\/j.parepi.2020.e00156 (2020).","journal-title":"Parasite Epidemiol. Control"},{"key":"1097_CR54","doi-asserted-by":"crossref","unstructured":"Bruni, N. et al. Nanostructured delivery systems with improved leishmanicidal activity: a critical review. Int. J. Nanomed. 5289\u20135311 (2017).","DOI":"10.2147\/IJN.S140363"},{"key":"1097_CR55","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1067\/mjd.2003.218","volume":"48","author":"K Gardlo","year":"2003","unstructured":"Gardlo, K. et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J. Am. Acad. Dermatol. 48, 893\u2013896. https:\/\/doi.org\/10.1067\/mjd.2003.218 (2003).","journal-title":"J. Am. Acad. Dermatol."},{"key":"1097_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1751-1097.1992.tb04222.x","volume":"55","author":"BW Henderson","year":"1992","unstructured":"Henderson, B. W. & Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol. 55, 145\u2013157 (1992).","journal-title":"Photochem. Photobiol."},{"key":"1097_CR57","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1542\/peds.95.6.882","volume":"95","author":"R Faris","year":"1995","unstructured":"Faris, R., Jarallah, J., Khoja, T. & Al-Yamani, M. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. Pediatrics 95, 882\u2013882 (1995).","journal-title":"Pediatrics"},{"key":"1097_CR58","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1517\/14712598.2014.945415","volume":"14","author":"A Khamesipour","year":"2014","unstructured":"Khamesipour, A. Therapeutic vaccines for leishmaniasis. Expert Opin. Biol. Ther. 14, 1641\u20131649 (2014).","journal-title":"Expert Opin. Biol. Ther."},{"key":"1097_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaad.2007.01.016","volume":"57","author":"A Khatami","year":"2007","unstructured":"Khatami, A., Firooz, A., Gorouhi, F. & Dowlati, Y. Treatment of acute old world cutaneous leishmaniasis: a systematic review of the randomized controlled trials. J. Am. Acad. Dermatol. 57, 335 (2007). e331-335. e329.","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01097-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01097-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01097-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T12:03:21Z","timestamp":1746878601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01097-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1097"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01097-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The present study was approved by the Ethics Committee of Kerman University of Medical Sciences, Kerman, Iran (Approval ID. IR.KMU.REC.1400.071).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}],"article-number":"16282"}}